FR2361906A1 - Substance antibiotique sf-1771 et substance antibiotique sf-1771-b, ainsi que preparation de ces substances - Google Patents

Substance antibiotique sf-1771 et substance antibiotique sf-1771-b, ainsi que preparation de ces substances

Info

Publication number
FR2361906A1
FR2361906A1 FR7633352A FR7633352A FR2361906A1 FR 2361906 A1 FR2361906 A1 FR 2361906A1 FR 7633352 A FR7633352 A FR 7633352A FR 7633352 A FR7633352 A FR 7633352A FR 2361906 A1 FR2361906 A1 FR 2361906A1
Authority
FR
France
Prior art keywords
antibiotic substance
reagent
substance
hydrochloride
soluble
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7633352A
Other languages
English (en)
French (fr)
Other versions
FR2361906B1 (ref
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Meiji Seika Kaisha Ltd
Original Assignee
Meiji Seika Kaisha Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP50129306A external-priority patent/JPS5831196B2/ja
Priority claimed from JP4989276A external-priority patent/JPS52133902A/ja
Application filed by Meiji Seika Kaisha Ltd filed Critical Meiji Seika Kaisha Ltd
Publication of FR2361906A1 publication Critical patent/FR2361906A1/fr
Application granted granted Critical
Publication of FR2361906B1 publication Critical patent/FR2361906B1/fr
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P1/00—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes
    • C12P1/06—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes by using actinomycetales
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/465—Streptomyces

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biomedical Technology (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • Mycology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Compounds Of Unknown Constitution (AREA)
FR7633352A 1975-10-29 1976-10-29 Substance antibiotique sf-1771 et substance antibiotique sf-1771-b, ainsi que preparation de ces substances Granted FR2361906A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP50129306A JPS5831196B2 (ja) 1975-10-29 1975-10-29 Ｓｆ−１７７１ ブツシツノ セイゾウホウ
JP4989276A JPS52133902A (en) 1976-05-04 1976-05-04 Novel antibiotic substance sf-1771-b and its preparation

Publications (2)

Publication Number Publication Date
FR2361906A1 true FR2361906A1 (fr) 1978-03-17
FR2361906B1 FR2361906B1 (ref) 1980-09-26

Family

ID=26390336

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7633352A Granted FR2361906A1 (fr) 1975-10-29 1976-10-29 Substance antibiotique sf-1771 et substance antibiotique sf-1771-b, ainsi que preparation de ces substances

Country Status (4)

Country Link
CA (1) CA1082626A (ref)
DE (1) DE2649604C2 (ref)
FR (1) FR2361906A1 (ref)
GB (1) GB1540466A (ref)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1292081A (en) * 1969-02-15 1972-10-11 Zaidan Hojin Biseibutsu Process for producing bleomycin antibiotics
JPS5243917B1 (ref) * 1971-02-13 1977-11-02
JPS5547039B2 (ref) * 1972-02-17 1980-11-27
JPS5128718B2 (ref) * 1972-09-07 1976-08-20
US4051237A (en) * 1975-08-28 1977-09-27 Bristol-Myers Company Glycopeptide antibiotics bu-2231 a and b and process for producing same

Also Published As

Publication number Publication date
CA1082626A (en) 1980-07-29
GB1540466A (en) 1979-02-14
DE2649604A1 (de) 1977-05-05
FR2361906B1 (ref) 1980-09-26
DE2649604C2 (de) 1984-04-05

Similar Documents

Publication Publication Date Title
Loomer et al. A clinical and pharmacodynamic evaluation of iproniazid as a psychic energizer.
ES2052717T3 (es) Uso de derivados de indolona para la preparacion de medicamentos para el tratamiento de la enfermedad de parkinson.
HUP0002373A2 (hu) Glükagon antagonisták/inverz agonisták és ezeket tartalmazó gyógyászati készítmények
FR2405711A1 (fr) Composition pharmaceutique contenant de l'amoxycilline et du clavulanate de potassium
NO953699L (no) Isolerte nukleinsyremolekyler som koder for tumor-rejeksjonsforlöperen MAGE-3, samt anvendelser derav
KR950700060A (ko) 운동 뉴우런 질병의 치료에 유용한 약품을 얻기 위한 2-아미노-6-트리플루오로메톡시 벤조티아졸(리루졸)의 사용(Application of 2-amino 6-trifluoromethoxy benzothiazole(riluzole) for obtaining a drug useful in the treatment of motor neuron diseases)
EP0217206A3 (en) Medicament against chronic graft-versus-host diseases, as well as against autoimmune diseases, particularly systemic lupus erythematodes
DE3681466D1 (de) Insulin-receptor, seine reinigung, seine herstellung in rekombinanten zellen, dna hierfuer, antikoerper gegen den insulin-receptor und deren herstellung, sowie pharmazeutische zusammensetzungen, die diese antikoerper enthalten.
FR2700117B1 (fr) Application d'anticonvulsivants dans le traitement de la maladie de Parkinson et des syndromes parkinsoniens.
KR950703953A (ko) 2-아미노-6-n-프로필아미노-4, 5, 6, 7-테트라하이드로벤조티아졸(프라미펙솔)의 항우울제로서의 용도(Use of 2-amino-6-n-propylamino-4, 5, 6, 7-tetrahydrobenzothiazole (pramipexol)as an antidepressant drug)
KR860002525A (ko) 거 담 약
BR9307746A (pt) Derivados de esteróides especificos para otratamento de cólon e ileo
BR9811137A (pt) Processo para redução de hiperglicemia e processo para redução de hiperglicemia e estabilização do nìvel de glicose sérica, composição farmacêutica, e, uso de tripicolinato crÈmico sintético
DE69534024D1 (de) Peptide und pharmazeutische zusammensetzungen, die diese enthalten
ROSNER et al. Cytotoxic drugs and leukaemogenesis
AU623649B2 (en) New sulphurcontaining eicosanoides and their application in pharmacy and in cosmetics
HUP9800613A2 (hu) Humán Fas-antigén elleni humanizált antitest
ATE92320T1 (de) Kombinationspraeparate enthaltend rifampicin und thioacetazon sowie gegebenenfalls isonicotinsaeurehydrazid oder ethambutol als aktive wirkstoffe.
CS55990A3 (en) Phenylhydrazones, process of their preparation and cosmetic preparations and pharmaceuticals made therefrom
TR199801184T2 (xx) Analjezik tesirli yeni bile�ikler.
BR9707776A (pt) Utilização da il-7 no tratamento das doenças autoimunes em especial o diabetes mellitus dependente de insulina
PAPPENFORT et al. Amodiaquin (Camoquin) in the Treatment of Chronic Discoid Lupus Erythematosus: Preliminary Report, with Special Reference to the Successful Response of Patients Resistant to Other Antimalarial Drugs
Goldsmith et al. Sj? gren-Larsson syndrome. Diversity of cutaneous manifestations
NAKAJIMA et al. Acanthocephalus opsariichthydis Yamaguti, 1935, from cultured rainbow trout, Salmo gairdnerii irideus, in Japan
FR2374036A1 (fr) Compositions pharmaceutiques contenant de la 3-phenoxypyridine

Legal Events

Date Code Title Description
ST Notification of lapse